Benzinga's Top #PreMarket Gainers

By: via Benzinga
Esperion Therapeutics (NASDAQ: ESPR) shares jumped 29.89% to $31.72 in pre-market trading after the company announced positive top-line ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.